Clinical Trial Update: Nutraceutical Combination in Patients With Low-grade Systemic Inflammation [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on a nutraceutical combination in patients with low-grade systemic inflammation, including those with atherosclerosis and hypercho…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Hypercholesterolemia
• Inflammation

Drugs mentioned

• Nutraceutical combination

Snippet

Sponsor: University Of Perugia | Conditions: Atherosclerosis, Inflammation | Phase 4 | Status: COMPLETED